Gucci Goes for Gold (and Diamonds, Too)

Image Solitaire rings from Gucci’s first haute jewelry collection, in yellow and white gold with tourmalines of about 10 carats each and, in the center ring, a 14-carat garnet.CreditRoberto Frankenberg for The New York Times PARIS — Gucci’s much-touted inclusivity is not limited to community: It extends to products, too. There is little, it seems,…

Details

Targeted therapy combination improves survival in patients with advanced bowel cancer

IMAGE: LBA-006 ‘BEACON CRC: a randomized, 3-Arm, phase 3 study of encorafenib and cetuximab with or without binimetinib vs. choice of either irinotecan or FOLFIRI plus cetuximab in BRAF V600E-mutant metastatic… view more  Credit: European Society for Medical Oncology Barcelona, Spain, 6 July 2019 – New data have shown for the first time that a combination…

Details

Data demonstrate efficacy of more flexible dose of regorafenib to relieve side-effects in mCRC patients

IMAGE: Abstract O-026 – ‘Results of REARRANGE trial: A randomized phase 2 study comparing different dosing approaches for regorafenib (REG) during the first cycle of treatment in patients (pts) with metastatic… view more  Credit: Courtesy of VHIO Barcelona, Spain, 6 July 2019 – Medical oncologists administer anticancer drug regorafenib to try to improve overall survival in…

Details

Triplet-targeted therapy improves survival for patients with advanced colorectal cancer and BRAF mutations

IMAGE: The trial results will be reported at the ESMO World Congress on Gastrointestinal Cancer 2019 by principal investigator Scott Kopetz, M.D., associate professor of Gastrointestinal Medical Oncology. view more  Credit: MD Anderson Cancer Center BARCELONA — The three-drug combination of encorafenib, binimetinib and cetuximab significantly improved overall survival (OS) in patients with BRAF-mutated metastatic colorectal…

Details